Key Studies of Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021

September 29 - October 3, 2021; Virtual
In this downloadable slideset, CCO’s expert faculty summarizes important studies from IDWeek 2021, including new data on vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.07 MB
Released: November 3, 2021

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Experts review therapeutic interventions for NAFLD/NASH, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH
Program Director
Rohit Loomba, MD, MHSc Brent Tetri, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Physician Assistants: 1.5 AAPA Category 1 CME Credits Released: December 7, 2022 Expired: December 6, 2023

Get the latest evidence-based updates on systemic, targeted therapies for the management of moderate to severe atopic dermatitis for patients of all ages!

Robert Sidbury, MD, MPH Jonathan Silverberg, MD Released: December 6, 2022

Unlocked downloadable slides featuring an overview of the challenges of traditional anemia treatment in patients with CKD, from Clinical Care Options (CCO)

person default Ajay Singh, MBBS, FRCP, MBA Released: November 18, 2022

Concise microlearning module featuring expert insight on challenges of traditional treatment of anemia of CKD from Clinical Care Options (CCO)

person default Ajay Singh, MBBS, FRCP, MBA Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Physician Assistants: 0.5 AAPA Category 1 CME credits Released: November 18, 2022 Expired: November 17, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings